Anzeige
Mehr »
Login
Donnerstag, 09.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
NurExone Biologic: Erfahren Sie mehr über den Biotech-Gral!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema VIVANI MEDICAL

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
23.04.Vivani Medical files for $300M mixed shelf2
26.03.Vivani Medical, Inc. - 10-K, Annual Report3
26.03.Vivani Medical Inc reports results for the quarter ended in December - Earnings Summary4
26.03.Vivani Medical GAAP EPS of -$0.121
26.03.Vivani Medical, Inc. - 8-K, Current Report2
26.03.Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results104ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, long-term drug implants including its lead...
► Artikel lesen
22.03.Vivani Medical Inc expected to post a loss of 14 cents a share - Earnings Preview3
06.03.Vivani Medical rises after appointing former Amylin Pharmaceuticals CEO to its board7
06.03.Vivani Medical, Inc. - 8-K, Current Report-
06.03.Vivani Medical welcomes industry veteran to board5
06.03.Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant16
01.03.Vivani Medical announces pricing of $15M registered direct offering4
01.03.Vivani Medical secures $15 million in direct offering4
29.02.Vivani Medical (VANI) stock price surged: is it a good buy?8
28.02.Why Is Vivani Medical (VANI) Stock Up 300% Today?8
28.02.Vivani Medical, Inc. - 8-K, Current Report3
28.02.EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows16
10.01.Vivani Medical, Inc. - 8-K, Current Report2
04.01.Vivani Medical And 2 Other Stocks Under $5 Insiders Are Buying6
27.12.23Vivani Medical, Inc. - 8-K, Current Report1
Seite:  Weiter >>